PHARMACOKINETICS
Clinical trials for PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental pill called IPG7236 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 196 adults will take the pill twice daily in …
Matched conditions: PHARMACOKINETICS
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New insulin copycat put to the test in healthy volunteers
Disease control Recruiting nowThis study checks if a new rapid-acting insulin (I004) works the same as the approved insulin NovoLog. About 60 healthy adults will receive a single dose of each insulin in a random order, and their blood sugar levels will be carefully controlled using a special clamp technique. …
Matched conditions: PHARMACOKINETICS
Phase: PHASE2, PHASE3 • Sponsor: Amphastar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Are we giving the right antibiotic doses to sick kids?
Knowledge-focused Recruiting nowThis study looks at whether standard antibiotic doses are effective for children in the pediatric intensive care unit. Researchers will measure drug levels in the blood of 640 children to see if they reach the right targets to fight infections. The goal is to improve dosing guide…
Matched conditions: PHARMACOKINETICS
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 17, 2026 03:10 UTC
-
New inhaled drug RCS-21 put to first safety test in humans
Knowledge-focused Recruiting nowThis early-stage study tests whether a single inhaled dose of RCS-21 is safe and tolerable in 24 healthy volunteers aged 18 to 64. Participants receive either the drug or a placebo and are closely monitored for side effects and how the drug moves through the body. The study does …
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Are we giving the right antibiotic doses to kids on ECMO?
Knowledge-focused Recruiting nowThis study looks at how antibiotics work in critically ill newborns, infants, and children who are on a life-support machine called ECMO. The goal is to see if current doses are enough to fight infections. Researchers will measure drug levels in the blood of 300 children to find …
Matched conditions: PHARMACOKINETICS
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
New antibiotic combo tested in healthy volunteers – no cure yet
Knowledge-focused Recruiting nowThis early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam) in about 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Results will help decide if further testing is possible.
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Healthy volunteers needed to test two versions of heart drug
Knowledge-focused Recruiting nowThis study tests how two different forms of the drug evolocumab (used to lower cholesterol) behave in the body. About 400 healthy adults aged 18 to 60 will receive a single dose of one version, and researchers will measure drug levels and side effects. The goal is to compare the …
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Healthy volunteers test new Abuse-Deterrent painkiller combo
Knowledge-focused Recruiting nowThis study tests how a new painkiller called PF614, given with another drug called nafamostat, moves through the body. 54 healthy adults aged 18-55 will receive a single dose and have their blood levels measured. The goal is to understand the drug's behavior, not to treat any con…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Ensysce Biosciences • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
New study aims to tailor antifungal dosing for sick kids
Knowledge-focused Recruiting nowThis study looks at how the antifungal medicine caspofungin behaves in children with severe infections in the intensive care unit. Researchers want to understand how conditions like liver problems or ECMO treatment affect the drug's levels in the body. The goal is to find the rig…
Matched conditions: PHARMACOKINETICS
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC
-
Kava and kratom combo under the microscope: new study reveals how they interact
Knowledge-focused Recruiting nowThis study looks at how the body processes kava and kratom when taken together compared to taking each one alone. It involves 18 healthy adults who will try all three options in a random order. The goal is to understand any interactions, not to treat any disease.
Matched conditions: PHARMACOKINETICS
Phase: NA • Sponsor: Botanic Tonics, LLC • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC
-
Scientists smoke out cannabis effects after a break
Knowledge-focused Recruiting nowThis study looks at how smoking high-potency cannabis changes pain perception and feelings of a "good drug effect" in people who use it almost daily. Researchers will compare results when participants use cannabis as usual versus after a short period of not using it. The goal is …
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC
-
Gum disease study seeks perfect antibiotic recipe
Knowledge-focused Recruiting nowThis study looks at how antibiotics like amoxicillin and metronidazole work in the body when used with deep cleaning for severe gum disease. Researchers want to find the best dose and treatment length (3 vs 7 days) to kill harmful bacteria without overusing antibiotics. About 45 …
Matched conditions: PHARMACOKINETICS
Phase: PHASE4 • Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:05 UTC